Sensitivity and specificity of different antibody tests for detecting varicella-zoster virus.


Journal

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
ISSN: 1437-7780
Titre abrégé: J Infect Chemother
Pays: Netherlands
ID NLM: 9608375

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 16 03 2020
revised: 18 07 2020
accepted: 26 07 2020
pubmed: 28 8 2020
medline: 25 6 2021
entrez: 27 8 2020
Statut: ppublish

Résumé

Antibody tests for detecting varicella-zoster virus include the fluorescent-antibody-to-membrane-antigen (FAMA) assay, immune adherence hemagglutination assay (IAHA), enzyme immunoassay (EIA), and the glycoprotein-based enzyme-linked immunosorbent assay (gpELISA). Although FAMA and gpELISA are highly sensitive, FAMA is not available commercially. Therefore, this study was performed to compare potential high-sensitivity tests with commercially available tests. Four antibody tests, FAMA, gpELISA, EIA, and IAHA, were performed using sera collected from 32 children aged 7 months-10 years. Using FAMA as a reference, the sensitivity and specificity of gpELISA, EIA, and IAHA were assessed. Subsequently, using gpELISA as a reference, the positive agreement rate of EIA and IAHA was assessed. On a reference scale with FAMA set at 100%, the sensitivity and specificity of the antibody tests were as follows: gpELISA, 67% and 100%; EIA, 67% and 100%; and IAHA, 47% and 100%, respectively. The positive agreement rates of EIA and IAHA relative to gpELISA were 86% and 64%, respectively. gpELISA had a lower positive rate than did FAMA, and showed comparable sensitivity to that of EIA.

Identifiants

pubmed: 32843302
pii: S1341-321X(20)30263-4
doi: 10.1016/j.jiac.2020.07.012
pii:
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1283-1287

Informations de copyright

Copyright © 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None.

Auteurs

Naruhito Otani (N)

Department of Public Health, Hyogo College of Medicine, Nishinomiya, Japan. Electronic address: naruhito@fa2.so-net.ne.jp.

Masayuki Shima (M)

Department of Public Health, Hyogo College of Medicine, Nishinomiya, Japan.

Susumu Tanimura (S)

Department of Public Health Nursing, Mie University Graduate School of Medicine, Tsu, Mie, Japan.

Takashi Ueda (T)

Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Japan.

Kaoru Ichiki (K)

Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Japan.

Kazuhiko Nakajima (K)

Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Japan.

Yoshio Takesue (Y)

Department of Infection Control and Prevention, Hyogo College of Medicine, Nishinomiya, Japan.

Kenta Honjo (K)

Kanonji Institute, The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan.

Toshiomi Okuno (T)

Department of Microbiology, Hyogo College of Medicine, Nishinomiya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH